Low-dose prophylaxis for children with haemophilia in a resource-limited setting in south India-A clinical audit report

N. Sidharthan, R. Sudevan, V. Narayana Pillai, S. Mathew, M. Raj, D. Viswam, C. Joseph, A. Sudhakar
  • Haemophilia, May 2017, Wiley
  • DOI: 10.1111/hae.13272

Low dose prophylaxis in Hemophilia in South India

What is it about?

Prophylaxis for children with Hemophilia at low dose factors is feasible in a resource poor setting and is far superior to the conventional on demand treatment

Why is it important?

More than 95% of treatment in the developing world is now on demand. We worked out a simple strategy for prophylaxis in real world setting which can be emulated quite easily in a resource poor setting


Neeraj Sidharthan (Author)
Amrita Vishwa Vidyapeetham

This publication is on our experience on a cohort of children with haemophilia with low dose factor VIII and IX prophylaxis. The background was resource limitation. The result showed,tht prophylaxis, even in low doses, is far superior to on demand treatment. We believe this is a model which the developing world can emulate

The following have contributed to this page: Dr.N.Vijayakumar NARAYANA PILLAI, manu raj, and Neeraj Sidharthan